skin cancer

A small, but significant, association between alcohol consumption and non-melanoma skin cancers has been found in a new systematic review. The most common of these types of cancer are squamous cell and basal cell carcinoma. Although the news is obviously a cause for concern, non-melanoma skin cancers are far less aggressive than malignant melanoma, a… Read more

New research has revealed important clues about one of the most mysterious types of cellular invaders, called polyomaviruses. The findings could aid the search for new treatments or preventive strategies against the problems that polyomaviruses can cause, including the deadly skin cancer Merkel cell carcinoma, and the fatal problems in people who are immuno-compromised because… Read more

Unique immune cells, known as resident memory T cells, do an excellent job of preventing melanoma, researchers at Dartmouth University report in a newly published study. Their finding stems from an investigation of why patients with melanoma who develop the autoimmune disease called vitiligo, have such good prognosis. Vitiligo is an autoimmune skin condition against… Read more

Accelerated approval has been granted by the FDA for the checkpoint inhibitor avelumab (brand name Bavencio) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. Avelumab is the first FDA-approved treatment for metastatic MCC, the first disease that the drug has been approved to treat… Read more

A new drug combination developed to kill melanoma cancer cells travels on nanoparticles, which are several hundred times smaller than the width of a hair. The drug, called CelePlum-777, combines a special ratio of the drugs Celecoxib, an anti-inflammatory, and Plumbagin, a toxin. Exposed to the drug, the melanoma cells have difficulty overcoming the effect… Read more